Akari Therapeutics Plc
SEC Filing List
AKTX CIK: 0001541157
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 05/22/2026 | |
| PRE 14A | Preliminary proxy statement not related ... | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 05/22/2026 | |
| RW | Registration Withdrawal Request | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 05/21/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 05/19/2026 | |
| NT 10-Q | Notice under Rule 12b25 of inability to ... | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 05/18/2026 | |
| S-1 | General form of registration statement f... | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 05/08/2026 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 04/15/2026 | ||
| POS AM | Post-effective amendment to a registrati... | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 04/10/2026 | |
| DRS | Draft registration statement submitted b... | Akari Therapeutics Plc | M2 COMPLIANCE LLC /fa | 04/02/2026 | |
| F-6/A | Amendment to Registration statement for ... | Deutsche Bank Trust Co Americas/ Adr Group | SEWARD & KISSEL LLP /fa | 03/31/2026 | |
| No record found. | |||||
| Load More | |||||
